News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Isabelle Ray-Coquard: New publication from ENGOTov25 Paola-1 study
centreleonberard.fr
Dec 12, 2024, 16:06

Isabelle Ray-Coquard: New publication from ENGOTov25 Paola-1 study

Isabelle Ray-Coquard, Medical Oncologist at Léon Bérard Center, shared a post on LinkedIn, about a paper by her and colleagues, published in Annals of Oncology:

“Paola-1 publications, new episode in Annals of Oncology 2024 revealing that subsequent therapies can be impacted differently after 1st line maintenance with parpi and bevacizumab or bevacizumab alone…

Very proud to share this academic international collaborative new publication from ENGOTov25 Paola-1 study.”

“Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.”

Authors: P. Harter, C. Marth, M. Mouret-Reynier, E. Pujade-Lauraine, I. Ray-Coquard et al.

Isabelle Ray-Coquard: New publication from ENGOTov25 Paola-1 study

More posts featuring Isabelle Ray-Coquard.

Annals of Oncology cancer ENGOTov25 Paola-1 Isabelle Ray-Coquard OncoDaily Oncology
Special Coverage
Science
Apr 1, 2025, 07:29
Talha Badar: Predictors of CNS relapse in APL
Blog
Apr 1, 2025, 07:24
Jenny Seligmann: World-class discovery science and clinicians collaborating on colorectal trial cohorts
Opinion
Apr 1, 2025, 07:19
Yüksel Ürün: Low-dose CT for lung cancer screening in a high-risk population
Blog
Apr 1, 2025, 07:09
Virginia Galvín: Should critical medications be integrated into defense budgets?
Blog
Apr 1, 2025, 06:51
Kendra Paabo: The 3 worst words you can say to someone with cancer
Blog
Apr 1, 2025, 06:49
Ali Atoui: Honored to Receive the 2025 CHAMP Award from the American Society of Hematology
Drugs
Apr 1, 2025, 06:49
Tislelizumab (Tevimbra): What Patients need to know?
Blog
Apr 1, 2025, 06:34
Trainee Day provided a space for trainees to connect and grow within the EBMT community
Blog
Apr 1, 2025, 06:20
Abhishek Chatterjee: The inaugural Stryker Breast Care Oncoplastic Surgery course has finished
Insight
Apr 1, 2025, 04:51
MD Anderson Cancer Center broke ground on a new 470,000-square-foot facility in Sugar Land
Blog
Apr 1, 2025, 04:49
Katy Beckermann: Secondary Analysis of the TITAN Trial
Blog
Apr 1, 2025, 04:37
Akhil Santhosh: 4 year update of CheckMate 743 Study